NO2252275T3 - - Google Patents

Info

Publication number
NO2252275T3
NO2252275T3 NO09709833A NO09709833A NO2252275T3 NO 2252275 T3 NO2252275 T3 NO 2252275T3 NO 09709833 A NO09709833 A NO 09709833A NO 09709833 A NO09709833 A NO 09709833A NO 2252275 T3 NO2252275 T3 NO 2252275T3
Authority
NO
Norway
Application number
NO09709833A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2252275T3 publication Critical patent/NO2252275T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
NO09709833A 2008-02-13 2009-02-13 NO2252275T3 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2821808P 2008-02-13 2008-02-13
PCT/US2009/034162 WO2009103035A2 (en) 2008-02-13 2009-02-13 Templated open flocs of anisotropic particles for enhanced pulmonary delivery

Publications (1)

Publication Number Publication Date
NO2252275T3 true NO2252275T3 (ja) 2018-04-28

Family

ID=40955349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO09709833A NO2252275T3 (ja) 2008-02-13 2009-02-13

Country Status (7)

Country Link
US (6) US20090208582A1 (ja)
EP (1) EP2252275B1 (ja)
AU (1) AU2009214443B2 (ja)
CA (1) CA2723314C (ja)
DK (1) DK2252275T3 (ja)
NO (1) NO2252275T3 (ja)
WO (1) WO2009103035A2 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2252275T3 (ja) * 2008-02-13 2018-04-28
BRPI1011721B1 (pt) 2009-03-26 2021-11-16 Pulmatrix, Inc Formulações em pó seco inaláveis compreendendo sal de cátion de metal divalente e métodos para tratar doenças pulmonares
US8506799B2 (en) * 2009-09-09 2013-08-13 ClearCorp Suspended particle characterization system for a water processing facility
US9248110B2 (en) 2010-03-18 2016-02-02 Steven Lehrer Compositions and methods of treating and preventing lung cancer and lymphangioleiomyomatosis
WO2011115988A1 (en) * 2010-03-18 2011-09-22 Steven Lehrer Compositions and methods of treating and preventing lung cancer
US9228785B2 (en) 2010-05-04 2016-01-05 Alexander Poltorak Fractal heat transfer device
WO2012030664A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
WO2012030645A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
US9433576B2 (en) 2010-09-29 2016-09-06 Pulmatrix, Inc. Cationic dry powders
AU2011308865B2 (en) 2010-09-29 2017-01-05 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
WO2014186754A2 (en) 2013-05-16 2014-11-20 Board Of Regents The University Of Texas System Dry solid aluminum adjuvant-containing vaccines and related methods thereof
CN104274426A (zh) * 2013-07-03 2015-01-14 陆克塞纳医药公司 昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途
CN104274427A (zh) * 2013-07-03 2015-01-14 陆克塞纳医药公司 格拉司琼气溶胶组合物及其用途
WO2015054280A1 (en) 2013-10-08 2015-04-16 Lam Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
PL3107548T3 (pl) 2014-02-20 2022-10-31 Otitopic Inc. Suche formulacje w proszku do inhalacji
EP4218742A1 (en) 2014-04-04 2023-08-02 AI Therapeutics, Inc. An inhalable rapamycin formulation for treating age-related conditions
CA2991760A1 (en) 2014-07-31 2016-02-04 Otitopic Inc. Dry powder formulations for inhalation
KR20170095807A (ko) 2014-10-07 2017-08-23 램 테라퓨틱스, 인코포레이티드 폐 고혈압의 치료를 위한 흡입가능 라파마이신 제제
WO2016178704A1 (en) * 2015-05-01 2016-11-10 Board Of Regents, The University Of Texas System Multidrug brittle matrix compositions
BR112018004069A2 (pt) 2015-09-01 2021-07-13 First Wave Bio, Inc. composição farmacêutica sólida, preparação de enema compreendendo niclosamida, formulação de enema, uso de niclosamida e kit
US10550019B2 (en) 2016-04-08 2020-02-04 OptikTechnik LLC Automated dosing system and method with light profiling for wastewater filtration system
US10830545B2 (en) 2016-07-12 2020-11-10 Fractal Heatsink Technologies, LLC System and method for maintaining efficiency of a heat sink
KR102408798B1 (ko) 2016-10-14 2022-06-13 풀매트릭스 오퍼레이팅 컴퍼니, 인크 항진균성 건조 분말
US11918646B2 (en) 2017-12-11 2024-03-05 Board Of Regents, The University Of Texas System Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
WO2019204568A1 (en) * 2018-04-20 2019-10-24 Board Of Regents, The University Of Texas System Apparatus and methods for characterizing plume geometry
TW202200121A (zh) 2020-03-16 2022-01-01 美商費斯特威弗生技股份有限公司 治療方法
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
JP2023520018A (ja) 2020-04-01 2023-05-15 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム ニクロサミドの薬学的組成物
EP4158025A1 (en) 2020-05-26 2023-04-05 Gradalis, Inc. Methods for the treatment of viral respiratory infections
WO2022055817A1 (en) 2020-09-09 2022-03-17 Gradalis, Inc. Composition formulated into inhalable dosage forms for the treatment of lung|tumors
EP4337173A1 (en) 2021-05-12 2024-03-20 TFF Pharmaceuticals, Inc. Dry powder formulations of tacrolimus for administration by inhalation once daily (qd)
KR20240049392A (ko) * 2021-08-30 2024-04-16 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 단클론성 항체 건조 분말
US20230112800A1 (en) 2021-08-31 2023-04-13 Board Of Regents, The University Of Texas System Delayed release niclosamide formulation
WO2024059819A2 (en) 2022-09-15 2024-03-21 Tff Pharmaceuticals, Inc. Compositions of cannabinoids for delivery by inhalation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
JPH1112197A (ja) 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk 悪性腫瘍診断剤及び治療剤
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
US6585957B1 (en) * 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
US20040176391A1 (en) * 2002-12-31 2004-09-09 Nektar Therapeutics Aerosolizable pharmaceutical formulation for fungal infection therapy
AR028746A1 (es) 2000-06-23 2003-05-21 Norton Health Care Ltd Cartucho de dosis previamente medidas para inhalador de polvo seco accionado por la respiracion, el inhalador y un metodo de provision de dosis previamente medidas de polvo seco
JP2003146523A (ja) 2001-11-15 2003-05-21 Canon Inc 画像形成装置
WO2003090715A2 (en) * 2002-04-25 2003-11-06 Nektar Therapeutics Uk Ltd Particulate materials
GB0216562D0 (en) * 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
EP1556018A1 (en) * 2002-09-30 2005-07-27 Acusphere, Inc. Sustained release porous microparticles for inhalation
EP1589948A1 (en) 2003-01-15 2005-11-02 Dow Global Technologies Inc. Drug particles obtained by freezing onto a cold surface
EP1663159A4 (en) * 2003-09-10 2010-06-09 Map Pharmaceuticals Inc AEROSOL FORMULATIONS FOR THE DELIVERY OF DIHYDROERGOTAMINE TO THE SYSTEMIC CIRCULATION BY PULMONARY INHALATION
EP1789018A1 (en) 2004-08-27 2007-05-30 The Dow Chemical Company Enhanced delivery of drug compositions to treat life threatening infections
NO2252275T3 (ja) * 2008-02-13 2018-04-28

Also Published As

Publication number Publication date
US20210007971A1 (en) 2021-01-14
US20100221343A1 (en) 2010-09-02
AU2009214443A1 (en) 2009-08-20
AU2009214443B2 (en) 2013-10-10
US20090208582A1 (en) 2009-08-20
EP2252275A2 (en) 2010-11-24
WO2009103035A2 (en) 2009-08-20
US11364197B2 (en) 2022-06-21
WO2009103035A3 (en) 2009-11-12
US20220354778A1 (en) 2022-11-10
US20200069572A1 (en) 2020-03-05
US10434062B2 (en) 2019-10-08
US20190117557A1 (en) 2019-04-25
US10660850B2 (en) 2020-05-26
CA2723314C (en) 2017-01-10
EP2252275B1 (en) 2017-11-29
US10092512B2 (en) 2018-10-09
EP2252275A4 (en) 2013-11-06
DK2252275T3 (en) 2018-03-05
CA2723314A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
BR112016019572A2 (ja)
BRPI0917573A2 (ja)
BRPI0918697A2 (ja)
BRPI0917525A2 (ja)
BRPI0920750A2 (ja)
BRPI0919470A2 (ja)
BRPI0922455A2 (ja)
BRPI0917618A8 (ja)
BRPI0923734A2 (ja)
NO2252275T3 (ja)
BRPI0922669A2 (ja)
BRPI0915616A2 (ja)
BRPI0919811A2 (ja)
BRPI0920914A2 (ja)
BRPI0916284A2 (ja)
BRPI0922550A2 (ja)
BRPI0914852A2 (ja)
CH2352018H2 (ja)
BRPI0914820A2 (ja)
AR073287B1 (ja)
BRPI0919477A2 (ja)
BRPI0923127A (ja)
BRPI0923137A2 (ja)
CN300880559S (zh) 钥匙（hj）
CN300880750S (zh) 包装箱(无糖杏仁露)